Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laetitia Schmitt

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Environmental Research and Public Health|November 8, 2018
Economic Evaluation of Environmental Interventions: Reflections on Methodological Challenges and DevelopmentsLaura Bojke, Laetitia Schmitt, James Lomas, et al.
BMJ Global Health|December 14, 2021
Concomitant health benefits package design and research prioritisation: development of a new approach and an application to MalawiLaetitia Schmitt, Jessica Ochalek, Karl Claxton, et al.
BMJ Global Health|September 2, 2020
Practical metrics for establishing the health benefits of research to support research prioritisationBeth Woods, Laetitia Schmitt, Claire Rothery, et al.
Pharmacoeconomics|August 17, 2018
Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Evaluation of a NICE Single Technology AppraisalRos Wade, Alessandro Grosso, Emily South, et al.
Health Technology Assessment (Winchester, England)|September 30, 2021
Non-invasive imaging software to assess the functional significance of coronary stenoses: a systematic review and economic evaluationAna Duarte, Alexis Llewellyn, Ruth Walker, et al.
Journal of Medical Economics|December 6, 2024
Cost-utility analysis of newborn screening for spinal muscular atrophy in JapanAkira Hata, Akihito Uda, Satoru Tanaka, et al.
Health Technology Assessment (Winchester, England)|June 28, 2024
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment modelBeth Woods, Laetitia Schmitt, Dina Jankovic, et al.
BMJ Open|June 23, 2016
A pharmacoeconomic approach to assessing the costs and benefits of air quality interventions that improve health: a case studyJames Lomas, Laetitia Schmitt, Sally Jones, et al.
Tobacco Control|June 30, 2019
Evidence that an intervention weakens the relationship between adolescent electronic cigarette use and tobacco smoking: a 24-month prospective studyMark Conner, Sarah Grogan, Ruth Simms-Ellis, et al.
Health Technology Assessment (Winchester, England)|November 2, 2024
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment modelSue Harnan, Ben Kearns, Alison Scope, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Environmental Research and Public Health|November 8, 2018
Economic Evaluation of Environmental Interventions: Reflections on Methodological Challenges and DevelopmentsLaura Bojke, Laetitia Schmitt, James Lomas, et al.
BMJ Global Health|December 14, 2021
Concomitant health benefits package design and research prioritisation: development of a new approach and an application to MalawiLaetitia Schmitt, Jessica Ochalek, Karl Claxton, et al.
BMJ Global Health|September 2, 2020
Practical metrics for establishing the health benefits of research to support research prioritisationBeth Woods, Laetitia Schmitt, Claire Rothery, et al.
Pharmacoeconomics|August 17, 2018
Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Evaluation of a NICE Single Technology AppraisalRos Wade, Alessandro Grosso, Emily South, et al.
Health Technology Assessment (Winchester, England)|September 30, 2021
Non-invasive imaging software to assess the functional significance of coronary stenoses: a systematic review and economic evaluationAna Duarte, Alexis Llewellyn, Ruth Walker, et al.
Journal of Medical Economics|December 6, 2024
Cost-utility analysis of newborn screening for spinal muscular atrophy in JapanAkira Hata, Akihito Uda, Satoru Tanaka, et al.
Health Technology Assessment (Winchester, England)|June 28, 2024
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment modelBeth Woods, Laetitia Schmitt, Dina Jankovic, et al.
BMJ Open|June 23, 2016
A pharmacoeconomic approach to assessing the costs and benefits of air quality interventions that improve health: a case studyJames Lomas, Laetitia Schmitt, Sally Jones, et al.
Tobacco Control|June 30, 2019
Evidence that an intervention weakens the relationship between adolescent electronic cigarette use and tobacco smoking: a 24-month prospective studyMark Conner, Sarah Grogan, Ruth Simms-Ellis, et al.
Health Technology Assessment (Winchester, England)|November 2, 2024
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment modelSue Harnan, Ben Kearns, Alison Scope, et al.
Pageof 2